Skip to content

Clinical trials

Phase 1/2 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 1/2 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20052
20071
20081
20091
20101
20111
20122
20141
20153
20161
20191
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated6
Unknown status2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Protalex, Inc.2
Cairo University1
Case Comprehensive Cancer Center1
Centers for Disease Control and Prevention1
Children's Hospital Los Angeles1
Chongqing Peg-Bio Biopharm Co., Ltd.1
Cullinan Therapeutics Inc.1
Drexel University College of Medicine1
East and North Hertfordshire NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia23
Anemia6
Leukemia4
Neutropenia4
Purpura, Thrombocytopenic, Idiopathic4
Leukemia, Myelomonocytic, Chronic3
Neoplasms3
Anemia, Aplastic2
Anemia, Refractory2
Anemia, Refractory, with Excess of Blasts2

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.